BIOMAT Database Logo BIOMAT Database Logo

Radiolabelled bile acid clearance in control subjects and patients with liver disease. 1979

L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D002793 Cholic Acids The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics. Cholalic Acids,Acids, Cholalic,Acids, Cholic
D006000 Glycocholic Acid The glycine conjugate of CHOLIC ACID. It acts as a detergent to solubilize fats for absorption and is itself absorbed. Cholylglycine,Glycine Cholate,Glycocholate,Glycocholate Sodium,Glycocholic Acid, Sodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile

Related Publications

L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Bile acid clearance in liver disease.
December 1979, Gut,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Cholic acid clearance in normal subjects and in patients with liver disease.
September 1973, Helvetica medica acta,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Plasma disappearance of intravenously injected radiolabelled glycocholic acid in patients with liver disease.
April 1977, Australian and New Zealand journal of medicine,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
[Amino acid metabolism in liver disease: bile amino acids in normal subjects and patients of liver disease; chromatographic study].
September 1956, Rassegna di fisiopatologia clinica e terapeutica,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Serum bile acid concentrations in patients with liver disease.
January 1976, Scandinavian journal of gastroenterology,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Within-day fluctuations in serum bile-acid concentrations among normal control subjects and patients with hepatic disease.
February 1980, American journal of clinical pathology,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Fatty acid synthesis in vitro by liver tissue from control subjects and patients with alcoholic liver disease.
December 1986, Clinical science (London, England : 1979),
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Comparison of serum clearance and urinary excretion of mesobilirubinogen-H 3 in control subjects and patients with liver disease.
November 1971, Gastroenterology,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease.
February 1980, Gut,
L R Engelking, and S Barnes, and C A Dasher, and D C Naftel, and B I Hirschowitz
[Bile acid metabolism in hepatic tissue of healthy subjects and in patients with liver cirrhosis].
April 1973, Zeitschrift fur Gastroenterologie,
Copied contents to your clipboard!